Google
Trusted Resources: Community Center
Online support, community stories, financial assistance
Adam Gardiner Fund Incorporation Blog
The Adam Gardiner Fund Incorporation (AGF) raises money to support the Westmead Amyloidosis Centre in the treatment of amyloidosis, a group of diseases that cause a buildup of abnormal protein in tissues and bodily organs. The Fund also supports clinical research and aims to raise awareness for these life-threatening diseases.
The Adam Gardiner Fund’s mission is to raise funds & awareness for amyloidosis while working within the structure of Westmead Hospitals Immunology Department and its Institute for Immunology & Allergy Research (IIAR).
myBinderRelated Content
-
Transthyretin Cardiac Amyloidosis in Black AmericansTransthyretin-related cardiac amyloidosi...
-
FDA Approves Subcutaneous Daratumumab Plus VCd for Newly Diagnosed Light-Chain AmyloidosisThe FDA has approved daratumumab and h...
-
Novel Strategies for the Diagnosis and Treatment of Cardiac AmyloidosisSystemic amyloidoses are rare, complex d...
-
Inotersen Treatment for Patients With Hereditary Transthyretin AmyloidosisBackground: Hereditary transthyretin am...
-
Kerry Cho, MD, FACPDr. Kerry Cho is a nephrologist who care...
-
University of Arkansas for Medical Sciences Myeloma CenterUniversity of Arkansas for Medical Scien...
-
Understanding Light Chain AmyloidosisAmyloidosis refers to several different ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
